How Does Differin Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Differin Works
- Active Ingredient: Adapalene (0.1% w/w), a third‑generation topical retinoid with high lipophilicity and receptor selectivity.
- Primary Actions: Binds selectively to RARβ/γ receptors → normalises keratinocyte differentiation → prevents microcomedone formation. Exhibits potent anti‑inflammatory effects by inhibiting leukotriene B4 and neutrophil chemotaxis.
- Absorption & Metabolism: Minimal systemic absorption (<0.25%); metabolised in the skin via oxidation and glucuronidation; excreted primarily in bile and urine.
- Onset & Duration: Visible improvement begins at 4–8 weeks; maximal benefit at 12 weeks; sustained use maintains remission.
- Safety: Contraindicated in pregnancy; avoid UV exposure; contains propylene glycol and methylparahydroxybenzoate (may cause irritation or allergic reactions).
Differin (adapalene) is a third‑generation topical retinoid that works deep inside the pores to normalise skin cell turnover and reduce inflammation, offering a targeted solution for both comedonal and inflammatory acne. This guide explains the science behind its dual mechanism and what happens inside the body after application.
Important Safety Advice
Do NOT use Differin if you are pregnant, planning pregnancy, or allergic to adapalene or any excipient. Avoid contact with eyes, mouth, nostrils, and broken skin (cuts, eczema). If accidental contact occurs, rinse immediately with warm water. Severe allergic reactions (angioedema, facial swelling) require urgent medical attention. Avoid excessive sun or UV exposure during treatment.
Chemical Composition & Molecular Structure
Differin 0.1% gel contains the active substance adapalene (6‑[3‑(1‑adamantyl)‑4‑methoxyphenyl]‑2‑naphthoic acid), a synthetic naphthoic acid derivative with distinct physicochemical properties. Unlike natural retinoids, adapalene is highly lipophilic and stable in the presence of light and oxygen.
Structural & Physicochemical Profile
6‑[3‑(1‑adamantyl)‑4‑methoxyphenyl]‑2‑naphthoic acid
Molecular weight: 412.5 g/mol. LogP = 5.2 (high lipophilicity favours follicular targeting). pKa = 4.2 (weak acid, partially ionised at skin pH).
- Propylene glycol (E1520) – 40 mg: penetration enhancer; may cause irritation.
- Methyl parahydroxybenzoate (E218) – preservative; may provoke allergic reactions.
- Carbomer 940, poloxamer 182, disodium edetate, phenoxyethanol, sodium hydroxide, purified water.
🗒️ Pharmaceutical insight: The gel formulation uses propylene glycol to enhance adapalene delivery into the pilosebaceous unit while maintaining a non‑comedogenic base suitable for acne‑prone skin.
Mechanism of Action: Anti‑inflammatory & Comedolytic Pathways
Adapalene exerts its therapeutic effect through two complementary pathways: normalisation of follicular keratinisation and suppression of inflammation.
- Nuclear receptor activation: Adapalene selectively binds to retinoic acid receptors RARβ and RARγ (not RARα) in keratinocytes and sebocytes. The receptor complex modulates transcription of genes involved in cell differentiation (e.g., transglutaminase, involucrin) and reduces the cohesiveness of corneocytes, thereby preventing microcomedone formation.
- Anti‑inflammatory mechanism: Unlike first‑generation retinoids, adapalene directly inhibits chemotaxis of polymorphonuclear leukocytes and reduces pro‑inflammatory eicosanoids such as leukotriene B4 (LTB4). It also downregulates toll‑like receptor‑2 expression, diminishing the inflammatory response to Cutibacterium acnes.
| Biological Effect | Molecular Pathway | Clinical Outcome |
|---|---|---|
| Reduced comedogenesis | RARβ/γ‑mediated differentiation | ↓ microcomedones, blackheads, whiteheads |
| Anti‑inflammatory | Inhibition of LTB4, TLR‑2, neutrophil migration | ↓ inflammatory papules, pustules, erythema |
| Epidermal remodelling | Increased epidermal turnover | Improved texture, reduced post‑inflammatory hyperpigmentation |
🗒️ Physiological insight: Adapalene’s selectivity for RARβ/γ explains its improved tolerability compared to tretinoin, while the anti‑inflammatory component provides early reduction of lesion soreness.
Absorption, Distribution & Metabolism (Pharmacokinetics)
After topical application, adapalene exhibits unique pharmacokinetic behaviour due to its high lipophilicity and targeted delivery.
Percutaneous absorption
Systemic absorption is extremely low (<0.25% of applied dose). Radiolabelled studies show that most adapalene remains in the stratum corneum and accumulates in hair follicles, creating a drug reservoir that sustains activity for up to 24 hours.
Tissue distribution
Peak skin concentrations occur 2–6 hours after application. No significant systemic distribution occurs; plasma concentrations are below the limit of quantification (0.15 ng/mL) following chronic use.
Skin metabolism
Adapalene is metabolised in the epidermis and dermis via oxidative (CYP450 enzymes) and conjugative pathways (glucuronidation). The metabolites are inactive and do not accumulate systemically.
Metabolic Effects & Elimination
Because systemic exposure is negligible, adapalene does not induce the typical systemic retinoid metabolic effects (e.g., hypertriglyceridaemia, hepatotoxicity) seen with oral retinoids. The small fraction that reaches the circulation undergoes hepatic metabolism (oxidation, glucuronidation) and is excreted via the bile (approx. 60%) and urine (approx. 40%) as conjugated metabolites. The elimination half‑life is not quantifiable in humans but estimated to be <1 hour for the unchanged drug in plasma when measurable.
⚠️ Metabolic caution: No clinically relevant drug‑drug interactions have been identified with systemic medications, but concomitant topical irritants may increase local side effects.
Clinical Efficacy in Acne Management
Differin is indicated for acne vulgaris in adults and adolescents aged ≥12 years. Randomised controlled trials demonstrate:
- Lesion reduction: 40‑60% reduction in non‑inflammatory lesions and 30‑50% reduction in inflammatory lesions after 12 weeks.
- Onset of action: Initial improvement visible by week 4; optimal results at week 12 with continued use.
- Maintenance: Long‑term use (up to 6 months) sustains remission and prevents new comedone formation.
- Combination: When used with benzoyl peroxide or topical antibiotics (morning/evening separation), efficacy is enhanced without reducing tolerability.
The SMART (Symbicort Maintenance and Reliever Therapy) analogy is not applicable; however, adherence to once‑daily application is critical. Patients who stop early often experience relapse within 4‑6 weeks.
Differin FAQs
How long does it take for Differin to start working?
Most people notice improvement in skin texture and lesion count after 4–8 weeks. Maximum clinical benefit is usually seen at 12 weeks of consistent once‑daily use.
Can I use Differin with other acne treatments?
Yes, Differin can be used with benzoyl peroxide or topical clindamycin, but apply them in the morning and Differin at night to reduce irritation. Avoid using other exfoliating agents (salicylic acid, harsh scrubs) simultaneously.
Why does my skin get worse before it gets better?
An initial “purge” (temporary flare) occurs as adapalene accelerates the turnover of existing microcomedones into visible lesions. This typically subsides within 2–4 weeks, followed by sustained improvement.
Is Differin safe during pregnancy or breastfeeding?
Differin is contraindicated in pregnancy. If you become pregnant, stop treatment immediately and inform your doctor. During breastfeeding, avoid applying the gel on the chest to prevent infant exposure.
What should I do if I experience severe irritation?
Mild redness and peeling are common during the first weeks. If irritation becomes severe, reduce application frequency to every other night until skin adjusts, or pause and consult your doctor. Always use a gentle moisturiser and avoid UV exposure.
Need Differin with Personalised Guidance?
If you have mild‑to‑moderate acne and think adapalene could be right for you, a UK‑registered doctor can review your skin type, prescribe Differin, and give tailored application advice.
Secure Prescription & Next‑Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Acne ConsultationRelated Differin Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 31 March 2026
Next Review: 30 September 2026
Published on: 31 March 2026
Last Updated: 31 March 2026